Stericycle Company Profile (NASDAQ:SRCL)

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Stericycle, Inc. (NASDAQ:SRCL) released its earnings results on Thursday, May, 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.05 by $0.04. The company earned $892.40 million during the quarter, compared to analyst estimates of $874.34 million. Stericycle had a return on equity of 14.40% and a net margin of 5.23%. The company's revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.11 earnings per share. View Stericycle's Earnings History.

Stericycle is scheduled to release their next quarterly earnings announcement on Thursday, August, 3rd 2017. View Earnings Estimates for Stericycle.

15 brokerages have issued twelve-month target prices for Stericycle's stock. Their forecasts range from $10.00 to $108.00. On average, they anticipate Stericycle's stock price to reach $80.83 in the next twelve months. View Analyst Ratings for Stericycle.

Here are some recent quotes from research analysts about Stericycle stock:

• 1. According to Zacks Investment Research, "Stericycle has a competitive edge with the largest collection and transportation network in the industry, which reduces operating costs and allows it to compete effectively on both service and price perspectives. International growth rates are expected to accelerate due to increasing customer adoption and expansion into new lines of business. With Shred-it on board, Stericycle is expected to further enhance its core compliance solutions portfolio and offer specialized services, thereby augmenting its value proposition to clients. In addition, the acquisition pool of the company remains robust in multiple geographies and lines of business, providing a long-term growth platform for selling multiple services. However, low barriers to entry in the industry and stiff competition from local as well as global players significantly reduce its price control. Stericycle also underperformed the industry year to date." (7/5/2017)
• 2. Jefferies Group LLC analysts commented, "Even better than we were expecting and contrary to what was foreshadowed in the Jan 26 8-K, SRCL exceeded our 4Q EPS estimate by $0.05 (or 5%). The operational assumptions embedded in '17 guidance were also reaffirmed, though the mid-point of the range is $0.03 (or 1%) lower on a stronger FX headwind. Notably, the pricing resets are tracking as expected and the early pilot programs aimed at mitigating drag from future renewals are showing encouraging results." (2/16/2017)

Some companies that are related to Stericycle include Advanced Disposal Services (ADSW), Covanta Holding Corporation (CVA), US Ecology (ECOL), Casella Waste Systems (CWST), Biffa PLC (BIFF), Heritage-Crystal Clean (HCCI), Sharps Compliance Corp (SMED), Augean plc (AUG), Perma-Fix Environmental Services (PESI), Vertex Energy (VTNR), Marathon Patent Group (MARA) and Renewi PLC (SKS).

Stericycle's management team includes the folowing people:

• Mark C. Miller, Chairman of the Board
• Charles A. Alutto, President, Chief Executive Officer, Director
• Daniel V. Ginnetti, Chief Financial Officer, Executive Vice President
• Brent Arnold, Chief Operating Officer, Executive Vice President
• John P. Schetz, Executive Vice President, General Counsel
• Ruth-Ellen Abdulmassih, Executive Vice President and President, Communication & Related Services
• Michael J. Collins, Executive Vice President, President - Recall and Returns Management Services
• Brenda Frank, Executive Vice President, Chief People Officer
• Richard J. Hoffman, Senior Vice President, Chief Accounting Officer
• Jack W. Schuler, Lead Independent Director

Stericycle's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Clarkston Capital Partners LLC (0.83%), Alecta Pensionsforsakring Omsesidigt (0.46%), Swedbank (0.40%), Oakbrook Investments LLC (0.27%), Bank of Montreal Can (0.20%) and Rockefeller Financial Services Inc. (0.16%). Company insiders that own Stericycle stock include Daniel Ginnetti, John P Schetz, Mark C Miller, Mike S Zafirovski, Robert S Murley and Rodney F Dammeyer. View Institutional Ownership Trends for Stericycle.

Stericycle's stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Alecta Pensionsforsakring Omsesidigt, Douglas Lane & Associates LLC, Professional Advisory Services Inc., US Bancorp DE, Investment House LLC, Huntington National Bank and Exxonmobil Investment Management Inc. TX. Company insiders that have sold Stericycle stock in the last year include John P Schetz, Mark C Miller and Rodney F Dammeyer. View Insider Buying and Selling for Stericycle.

Stericycle's stock was purchased by a variety of institutional investors in the last quarter, including Clarkston Capital Partners LLC, Oakbrook Investments LLC, LGT Capital Partners LTD., Mn Services Vermogensbeheer B.V., Meeder Asset Management Inc., Swedbank, Sheets Smith Wealth Management and Boston Advisors LLC. Company insiders that have bought Stericycle stock in the last two years include Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.

Shares of Stericycle can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Stericycle stock can currently be purchased for approximately $77.46.